[Basic principal of the dual antithrombotic therapy achieved by cilostazol].
Goto
Shinya
S
Department of Medicine, Tokai University School of Medicine.
D000077407:Cilostazol; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use*; D013927:Thrombosis / Q000517:prevention & control*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D013777:Tetrazoles; D014665:Vasodilator Agents; D000077407:Cilostazol